Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ernexa Therapeutics (ERNA) Goodwill (2016 - 2025)

Historic Goodwill for Ernexa Therapeutics (ERNA) over the last 16 years, with Q3 2025 value amounting to $2.0 million.

  • Ernexa Therapeutics' Goodwill changed 0.0% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $2.0 million for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Ernexa Therapeutics reported Goodwill of $2.0 million as of Q3 2025, which was down 0.0% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, Ernexa Therapeutics' Goodwill registered a high of $2.0 million during Q1 2022, and its lowest value of $2.0 million during Q1 2021.
  • In the last 5 years, Ernexa Therapeutics' Goodwill had a median value of $2.0 million in 2022 and averaged $2.0 million.
  • As far as peak fluctuations go, Ernexa Therapeutics' Goodwill grew by 1.24% in 2022, and later changed by 0.0% in 2023.
  • Ernexa Therapeutics' Goodwill (Quarter) stood at $2.0 million in 2021, then grew by 0.01% to $2.0 million in 2022, then changed by 0.0% to $2.0 million in 2023, then changed by 0.0% to $2.0 million in 2024, then changed by 0.0% to $2.0 million in 2025.
  • Its Goodwill stands at $2.0 million for Q3 2025, versus $2.0 million for Q2 2025 and $2.0 million for Q1 2025.